Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

Abroad (travel likely)RecruitingPHASE1

Conditions

Hepatoblastoma · Hepatocellular Carcinoma · Wilms Tumor · Malignant Rhabdoid Tumor · Yolk Sac Tumor · Rhabdomyosarcoma · Liposarcoma · Embryonal Sarcoma of Liver

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Houston Methodist Hospital, Houston, Texas, United States
Contact: Study coordinator (Premal Lulla, MD) · lulla@bcm.edu · (713) 441-1450

Study leads

Premal Lulla, MD
Principal Investigator
Baylor College of Medicine
David Steffin, MD
Principal Investigator
Baylor College of Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

Solid Tumor (Excluding CNS) · Liver Cell Carcinoma · Malignant Rhabdoid Tumor

Abroad (travel likely)RecruitingPHASE1

Seattle, United States

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

Pediatric Solid Tumor · Osteosarcoma · Rhabdomyosarcoma

Abroad (travel likely)RecruitingPHASE1

Memphis, United States

Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies

Ewing Sarcoma · Rhabdomyosarcoma · Wilms Tumor

Abroad (travel likely)RecruitingPHASE1

Valhalla, United States

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Recurrent Solid Tumor · Recurrent Ewing Sarcoma · Recurrent Hepatoblastoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Palo Alto, United States · Aurora, United States